Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator

Transplantation

Volumn 75, Issue 8, 2003, Pages 1115-1118

  Nakamura, Yoshiichiroh ^a   Yasunami, Yohichi ^a   Satoh, Masayuki ^a   Hirakawa, Eiji ^a   Katsuta, Hitoshi ^a   Ono, Junko ^a   Kamada, Masafumi ^b   Todo, Satoru ^c   Nakayama, Toshinuri ^d   Taniguchi, Masaru ^d   Ikeda, Seryo ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JT Inc   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INDUCIBLE COSTIMULATOR; INDUCIBLE COSTIMULATOR ANTIBODY; TACROLIMUS; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; CONFERENCE PAPER; DIABETES MELLITUS; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; LIVER; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; ANTIBODIES; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DRUG SYNERGISM; GRAFT REJECTION; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; KILLER CELLS, NATURAL; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TACROLIMUS; UP-REGULATION;

EID: 0037469064     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000063705.80764.0F     Document Type: Conference Paper

References (12)

1. Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999; 397: 263.
2. Mages HW, Hutloff A, Heuck C, et al. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur J Immunol 2000; 30: 1040.
3. Yoshinaga SK, Whoriskey JS, Khare SD, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402: 827.
4. Ozkaynak E, Gao W, Shemmeri N, et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2001; 2: 591.
5. Guo L, Li X-K, Funeshima N, et al. Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS). Transplantation 2002; 73: 1027.
6. Ohtsuka K, Yasunami Y, Ikehara Y, et al. Expansion of intermediate T cell receptor cells expressing IL-2Rα-β+, CD8α+β+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: Prevention of rejection with anti-IL-2R β monoclonal antibody treatment. Transplantation 1997; 64: 633.
7. Sakamoto S, Tezuka K, Tsuji T, et al. AILIM/ICOS: Its expression and functional analysis with monoclonal antibodies. Hybridoma 2001; 20: 293.
8. + Vα14NKT cells are essential for the acceptance of intrahepatic rat islet xenografts in mice. J Clin Invest 2000; 105: 1761.
9. Ogawa S, Nagamatsu G, Watanabe M, et al. Opposing effects of anti-activation-inducible lymphocyte-immunomodulatory molecule/inducible costimulator antibody on the development of acute versus chronic graft-versus-host disease. J Immunol 2001; 167: 5741.
10. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787.
11. Tesciuba AG, Subudhi S, Rother RP, et al. Inducible costimulator regulates Th2-mediated inflammation, but not Th2 differentiation, in a model of allergic airway disease. J Immunol 2002; 167: 1996.
12. Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.